Citigroup’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.14M Sell
97,251
-62,909
-39% -$4.62M ﹤0.01% 1191
2025
Q1
$18.3M Buy
160,160
+15,915
+11% +$1.82M 0.01% 749
2024
Q4
$7.27M Sell
144,245
-461
-0.3% -$23.2K ﹤0.01% 1153
2024
Q3
$6.7M Buy
144,706
+48,270
+50% +$2.23M ﹤0.01% 1148
2024
Q2
$3.13M Sell
96,436
-10,515
-10% -$342K ﹤0.01% 1454
2024
Q1
$2.69M Buy
106,951
+28,079
+36% +$707K ﹤0.01% 1623
2023
Q4
$2.56M Buy
78,872
+27,054
+52% +$879K ﹤0.01% 1478
2023
Q3
$1.41M Sell
51,818
-35,116
-40% -$957K ﹤0.01% 1688
2023
Q2
$1.93M Buy
86,934
+14,248
+20% +$317K ﹤0.01% 1717
2023
Q1
$1.57M Sell
72,686
-2,072
-3% -$44.9K ﹤0.01% 1689
2022
Q4
$1.52M Buy
74,758
+3,823
+5% +$77.6K ﹤0.01% 1712
2022
Q3
$1.82M Buy
70,935
+2,168
+3% +$55.6K ﹤0.01% 1662
2022
Q2
$1.64M Sell
68,767
-34,474
-33% -$820K ﹤0.01% 1718
2022
Q1
$2.33M Buy
103,241
+13,488
+15% +$304K ﹤0.01% 1673
2021
Q4
$1.78M Buy
89,753
+2,396
+3% +$47.4K ﹤0.01% 2069
2021
Q3
$1.72M Sell
87,357
-964
-1% -$19K ﹤0.01% 2018
2021
Q2
$1.94M Buy
88,321
+48,373
+121% +$1.06M ﹤0.01% 2121
2021
Q1
$950K Sell
39,948
-15,978
-29% -$380K ﹤0.01% 2420
2020
Q4
$1.46M Sell
55,926
-30,200
-35% -$790K ﹤0.01% 1905
2020
Q3
$1.5M Sell
86,126
-36,624
-30% -$637K ﹤0.01% 1675
2020
Q2
$2.07M Buy
122,750
+29,642
+32% +$499K ﹤0.01% 1601
2020
Q1
$1.11M Sell
93,108
-14,582
-14% -$173K ﹤0.01% 1735
2019
Q4
$1.3M Sell
107,690
-32,144
-23% -$389K ﹤0.01% 2001
2019
Q3
$1.98M Buy
139,834
+49,335
+55% +$698K ﹤0.01% 1623
2019
Q2
$1.01M Sell
90,499
-39,596
-30% -$441K ﹤0.01% 2136
2019
Q1
$1.53M Sell
130,095
-80,198
-38% -$941K ﹤0.01% 1683
2018
Q4
$2.81M Buy
210,293
+104,784
+99% +$1.4M ﹤0.01% 1330
2018
Q3
$1.48M Sell
105,509
-100,526
-49% -$1.41M ﹤0.01% 1708
2018
Q2
$3.24M Buy
206,035
+159,380
+342% +$2.51M ﹤0.01% 1218
2018
Q1
$767K Sell
46,655
-202,837
-81% -$3.33M ﹤0.01% 1993
2017
Q4
$4.51M Buy
249,492
+4,674
+2% +$84.4K ﹤0.01% 1023
2017
Q3
$4.73M Buy
244,818
+69,604
+40% +$1.34M ﹤0.01% 994
2017
Q2
$2.07M Buy
175,214
+148,918
+566% +$1.76M ﹤0.01% 1466
2017
Q1
$288K Sell
26,296
-49,367
-65% -$541K ﹤0.01% 2745
2016
Q4
$549K Buy
75,663
+49,690
+191% +$361K ﹤0.01% 2818
2016
Q3
$169K Buy
25,973
+9,990
+63% +$65K ﹤0.01% 3085
2016
Q2
$88K Sell
15,983
-38,756
-71% -$213K ﹤0.01% 3402
2016
Q1
$256K Buy
54,739
+25,467
+87% +$119K ﹤0.01% 3275
2015
Q4
$146K Buy
29,272
+29,262
+292,620% +$146K ﹤0.01% 3297
2015
Q3
$0 Sell
10
-794
-99% ﹤0.01% 5258
2015
Q2
$5K Sell
804
-4,374
-84% -$27.2K ﹤0.01% 4823
2015
Q1
$29K Sell
5,178
-3,978
-43% -$22.3K ﹤0.01% 4173
2014
Q4
$27K Buy
9,156
+7,301
+394% +$21.5K ﹤0.01% 4448
2014
Q3
$5K Buy
1,855
+904
+95% +$2.44K ﹤0.01% 4901
2014
Q2
$3K Sell
951
-7,805
-89% -$24.6K ﹤0.01% 4976
2014
Q1
$38K Sell
8,756
-7,919
-47% -$34.4K ﹤0.01% 4138
2013
Q4
$54K Buy
16,675
+16,604
+23,386% +$53.8K ﹤0.01% 4108
2013
Q3
$0 Buy
71
+1
+1% ﹤0.01% 5152
2013
Q2
$0 Buy
+70
New ﹤0.01% 5094